drugset / Trial / NCT01952990
Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects
Phase 2
Completed
18 enrolled
St. Renatus, LLC
Analytical Bio-Chemistry Laboratories, Inc. · collabRho, Inc. · collabTriligent International · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacokinetics and safety of a nasal spray containing the anesthetic drug Tetracaine in combination with Oxymetazoline in healthy pediatric subjects.
Timeline
- Start
- 2013-09
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxymetazoline | Other / unclassified | 0.05 mg | Intranasal |
| Subject | Oxymetazoline | Other / unclassified | 0.1 mg | Intranasal |
| Subject | Oxymetazoline | Other / unclassified | 0.2 mg | Intranasal |
| Subject | tetracaine | Other / unclassified | 3 mg | Intranasal |
| Subject | tetracaine | Other / unclassified | 6 mg | Intranasal |
| Subject | tetracaine | Other / unclassified | 12 mg | Intranasal |
Indications
No indication recorded.